Rafli van de Laar

Cytoreductive surgery followed by chemotherapy versus chemotherapy alone for recurrent platinum-sensitive epithelial ovarian cancer (SOCceR trial): a multicenter randomised controlled study

Rafli van de Laar, Petra L.M. Zusterzeel, Toon Van Gorp et al. · BMC Cancer · 2014 · 57 citations · Full text

Medicine, Oncology, Surgery +16

Perioperative changes in serum CA125 levels: a prognostic factor for disease-specific survival in patients with ovarian cancer

Nienke Zwakman, Rafli van de Laar, Toon Van Gorp et al. · Journal of Gynecologic Oncology · 2016 · 37 citations · Full text

Medicine, Oncology, Surgery +17

External validation of two prediction models of complete secondary cytoreductive surgery in patients with recurrent epithelial ovarian cancer

Rafli van de Laar, Leon F.A.G. Massuger, Toon Van Gorp et al. · Gynecologic Oncology · 2015 · 33 citations

Medicine, Gynecology, Surgery +15

Impact of the COVID-19-pandemic on patients with gynecological malignancies undergoing surgery: A Dutch population-based study using data from the ‘Dutch Gynecological Oncology Audit’

Marc Daniël Algera, Willemien J. van Driel, B.F.M. Slangen et al. · Gynecologic Oncology · 2022 · 33 citations · Full text

Medicine, Oncology, Surgery +12

Surgery for Recurrent Epithelial Ovarian Cancer in the Netherlands

Rafli van de Laar, Roy F.P.M. Kruitwagen, Joanna IntHout et al. · International Journal of Gynecological Cancer · 2015 · 31 citations

Medicine, Oncology, Surgery +17